unusual volume coming into NEPH 🥶vol increase caught my eye, but still stuck in consolidation faze for now..
above 2.04 and I expect a big 30-100% rally to come 👀
−0.15USD
−1.58 MUSD
14.24 MUSD
9.18 M
About Nephros, Inc.
Sector
Industry
CEO
Robert Banks
Website
Headquarters
South Orange
Employees (FY)
31
Founded
1997
ISIN
US6406714005
FIGI
BBG000NXRTF2
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NEPH is 2.07 USD — it has increased by 1.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Nephros, Inc. stocks are traded under the ticker NEPH.
Nephros, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
NEPH stock is 1.93% volatile and has beta coefficient of 1.58. Check out the list of the most volatile stocks — is Nephros, Inc. there?
One year price forecast for Nephros, Inc. has a max estimate of 5.00 USD and a min estimate of 4.50 USD.
NEPH earnings for the last quarter are −0.02 USD per share, whereas the estimation was −0.07 USD resulting in a 69.23% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about Nephros, Inc. earnings.
Nephros, Inc. revenue for the last quarter amounts to 3.74 M USD despite the estimated figure of 3.37 M USD. In the next quarter revenue is expected to reach 3.81 M USD.
Yes, you can track Nephros, Inc. financials in yearly and quarterly reports right on TradingView.
NEPH stock has risen by 2.99% compared to the previous week, the month change is a 2.36% fall, over the last year Nephros, Inc. has showed a 43.75% increase.
NEPH net income for the last quarter is −654.00 K USD, while the quarter before that showed −182.00 K USD of net income which accounts for −259.34% change. Track more Nephros, Inc. financial stats to get the full picture.
Today Nephros, Inc. has the market capitalization of 21.40 M, it has decreased by 2.27% over the last week.
No, NEPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NEPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nephros, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 31.00 employees. See our rating of the largest employees — is Nephros, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nephros, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nephros, Inc. stock shows the sell signal. See more of Nephros, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Nephros, Inc. future price: according to them, NEPH price has a max estimate of 5.00 USD and a min estimate of 4.50 USD. Read a more detailed Nephros, Inc. forecast: see what analysts think of Nephros, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nephros, Inc. EBITDA is −1.15 M USD, and current EBITDA margin is −9.69%. See more stats in Nephros, Inc. financial statements.